| 000 | 01157 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517193102.0 | ||
| 264 | 0 | _c20181217 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1437-7799 | ||
| 024 | 7 |
_a10.1007/s10157-017-1525-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSakuraba, Hitoshi | |
| 245 | 0 | 0 |
_aPlasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy. _h[electronic resource] |
| 260 |
_bClinical and experimental nephrology _cAug 2018 |
||
| 300 |
_a843-849 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aEnzyme Replacement Therapy |
| 650 | 0 | 4 |
_aFabry Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycolipids _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSphingolipids _xblood |
| 650 | 0 | 4 | _aalpha-Galactosidase |
| 700 | 1 | _aTogawa, Tadayasu | |
| 700 | 1 | _aTsukimura, Takahiro | |
| 700 | 1 | _aKato, Hiroshi | |
| 773 | 0 |
_tClinical and experimental nephrology _gvol. 22 _gno. 4 _gp. 843-849 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10157-017-1525-3 _zAvailable from publisher's website |
| 999 |
_c27935510 _d27935510 |
||